The significant risk for oral cancer among carriers of both CYP1A1*2A homozygous variant and GSTM1 null genotype previously suggested by Anantharaman et al. [64] was also supported by Indian, Japanese, Korean, and Brazilian studies [62, 63, 68, 69]. This evidence concerns the gene CYP1A1 and lip and oral cavity carcinoma.